Found 15 matching trials
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors PHASE1 Avelumab in combination with talazoparib will be investigated in patients w...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. PHASE1 The purpose of this study is to look at the effectiveness, safety, and anti...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer PHASE2 The DOMEC trial is designed as a Dutch Gynecological Oncology Group (DGOG),...
Show More Location
Amsterdam UMC, AMC
Learn More & Join Trial
Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer NA Radiation therapy is a crucial part in the comprehensive treatment of breas...
Show More Location
Cancer Hospital ,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss PHASE2 ATARI trial tests the ATR inhibitor drug ceralasertib (AZD6738) alone and i...
Show More Status
Active Not Recruiting
Location
The Ottawa Hospital Cancer Centre
Learn More & Join Trial
Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors PHASE2 The primary objective of the trial is to evaluate the antitumor activity of...
Show More Learn More & Join Trial
A MolEcularly Guided Anti-Cancer Drug Off-Label Trial PHASE2 This is a prospective, open-label, non-randomized combined basket- and umbr...
Show More Status
Active Not Recruiting
Location
Sahlgrenska University Hospital
Learn More & Join Trial
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer PHASE2 This randomized phase II trial studies how well olaparib with or without at...
Show More Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Learn More & Join Trial